Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 9:30 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1273–1296 of 2,913 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Event Clear all

Conditions: Solid Tumors
Interventions: AUBE00, Cetuximab; Drug
Lead sponsor: Chugai Pharmaceutical; Industry
Eligibility: 18 Years and older
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 3
States / cities: Grand Rapids, Michigan • Houston, Texas • Fairfax, Virginia

Conditions: Suicidal Ideation, Suicide, Attempted, Ptsd
Interventions: Cognitive Processing Therapy (CPT), Crisis Response Plan (CRP), Safety Planning Intervention (SPI), Narrative Assessment; Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 157 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Intracerebral Haemorrhage, Intraventricular
Interventions: Pioglitazone 15mg; Drug
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 80 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Alcohol Abuse, IPV, Couples
Interventions: Heart Rate Variability-Biofeedback (HRV-B) via Smartwatch Device Intervention; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 21 Years to 70 Years
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Patient Admission, Patient Discharge
Interventions: Enhanced Discharge Planning Program transitional care; Behavioral
Lead sponsor: Rush University Medical Center; Other
Eligibility: 65 Years and older
Enrollment: 740 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Obesity, Methamphetamine Use Disorder
Interventions: Tirzepatide; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Atrial Fibrillation
Interventions: AI-enabled ECG-based Screening Tool for AF; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 1,225 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Non Alcoholic Fatty Liver Disease, Obstructive Sleep Apnea
Interventions: CPAP (ResMed S9 autoset CPAP); Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 21 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Stage IIIA Non-Small Cell Lung Cancer, Stage IIIB Non-Small Cell Lung Cancer
Interventions: Erlotinib Hydrochloride, Therapeutic Conventional Surgery, Laboratory Biomarker Analysis; Drug · Procedure · Other
Lead sponsor: Albert Einstein College of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 3
States / cities: New York, New York • The Bronx, New York

Conditions: Cerebral Palsy
Interventions: Dysport Injectable Product; Drug
Lead sponsor: Columbia University; Other
Eligibility: 5 Years to 17 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Hypertension, Retinal Disorder, Cognitive Impairment
Interventions: Not listed
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 234 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2020
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Depression
Interventions: Vortioxetine, Placebo; Drug
Lead sponsor: H. Lundbeck A/S; Industry
Eligibility: 7 Years to 11 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 3
States / cities: Long Beach, California • Atlanta, Georgia • Plano, Texas

Conditions: Chronic Pain
Interventions: PsychoEducation, Self-Hypnosis Training, Mindfulness Meditation; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 343 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 5
States / cities: Seattle, Washington • Tacoma, Washington

Conditions: Bipolar Disorder, Early Intervention
Interventions: Interpersonal and Social Rhythm Therapy; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 12 Years to 18 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Schizophrenia, Schizoaffective Disorder, Psychosis NOS
Interventions: Relapse Prevention Plan, Daily Support Website, Computer CBT for voices and paranoia, FOCUS, Prescriber Decision Assistant; Behavioral · Other
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years to 60 Years
Enrollment: 461 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 8
States / cities: Fort Lauderdale, Florida • Lawrenceburg, Indiana • Grand Rapids, Michigan + 5 more

Conditions: Vomiting, Nausea
Interventions: Acupressure, Ondansetron; Procedure · Drug
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Thrombosis
Interventions: Heparin; Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 1,015 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 4
States / cities: Rochester, Minnesota • Chapel Hill, North Carolina • Durham, North Carolina + 1 more

Conditions: Suicide, Chronic Pain
Interventions: Problem-solving treatment, Supportive Psychotherapy; Behavioral
Lead sponsor: Veterans BioMedical Research Institute; Other
Eligibility: 18 Years to 70 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: East Orange, New Jersey

Conditions: Infectious Disease
Interventions: Not listed
Lead sponsor: Midwestern University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 2,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Downers Grove, Illinois

Conditions: Cervical Ripening, Induction of Labor
Interventions: MVI 100, MVI 150, MVI 200; Drug
Lead sponsor: Ferring Pharmaceuticals; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 374 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 11
States / cities: Phoenix, Arizona • Tucson, Arizona • Long Beach, California + 8 more

Conditions: Suicide Prevention
Interventions: Virtual Crisis Response Planning, In-Person Crisis Response Planning, Crisis Risk Counseling; Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 14 Years to 18 Years
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Cancer
Interventions: ePRO; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Cardiovascular Disease and Lipoprotein(a)
Interventions: TQJ230, Placebo; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 8,323 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 287
States / cities: Andalusia, Alabama • Birmingham, Alabama • Huntsville, Alabama + 136 more

Conditions: Heart Failure
Interventions: Bodyport Cardiac Scale; Device
Lead sponsor: Bodyport Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 329 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 8
States / cities: Boynton Beach, Florida • Panama City, Florida • Gainesville, Georgia + 5 more

Search by objective public record fields.

Study of AUBE00 in Patients With Solid Tumors

Improving Treatment Outcomes for Suicidal Veterans With PTSD

Safety and Suitability of Supplementing Early MIP Surgery (MIPS) of ICH With Pioglitazone

Wearable Technology and Alcohol-Facilitated Intimate Partner Violence

Enhanced Discharge Planning Program -- Prospective

Tirzepatide for Obesity and Meth Use Disorder

Batch Enrollment for AI-Guided Intervention to Lower Neurologic Events in Unrecognized AF

The Sleep, Liver Evaluation and Effective Pressure Study

Erlotinib Hydrochloride Before Surgery in Treating Patients With Stage III Non-Small Cell Lung Cancer

Effect of Dysport Injections on Energy Expenditure and Walking Efficiency in Children With Cerebral Palsy

DETECT and Retinal Outcomes in Hypertension

Vortioxetine to Prevent Return of Symptoms in Children With Depression

Chronic Pain Skills Study

Early Assessment and Intervention for Adolescents at Risk for Bipolar Disorder

Improving Care and Reducing Cost Study

Post-Operative Therapy for Nausea or Vomiting

Risk of Developing Antibodies to Heparin-PF4 After Heart Surgery

Suicide Prevention for Patients With Chronic Pain

Antibiotic Outbreak, Risk Factors for Never Event, Prediction of Inappropriate Use

Misoprostol Vaginal Insert (MVI) 100, 150, 200 mcg for Cervical Ripening and Induction of Labor

Feasibility Trial of a Single Session of Crisis Response Planning for Youth at High Risk for Suicide

Digital Symptom Tracking, Patient Engagement and Quality of Life in GI Oncology Clinic Patients

Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD

Surveillance and Alert-based Multiparameter Monitoring to Reduce Worsening Heart Failure Events